DuPont Ag-Bio Startup Amfora Licenses CRISPR IP From Corteva, Broad Institute The San Francisco-based startup, which closed a $5 million Series A round in 2017, aims to develop nutritionally enhanced food and feed crops. Broad, DuPont Pioneer Partner to Provide Non-Exclusive Licenses to CRISPR IP The collaborators will grant the licenses to any entities wanting to use the technology for commercial agricultural research and product development. DuPont Pioneer Licenses CRISPR Tech From ERS Genomics DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications. Hygiena Acquires DuPont Global Food Safety Diagnostics Business The company said its acquisition of DuPont Diagnostics will allow it to provide a broader array of food safety diagnostics services to its customers. DuPont Inks CRISPR/Cas9 Deal With International Maize and Wheat Improvement Center DuPont Pioneer has entered into a collaboration to apply CRISPR genome editing to the development of crop varieties for farmers in developing countries. Jul 13, 2016 Thermo Fisher, DuPont Extend Food Safety Testing Distribution Pact for Western Europe Nov 20, 2015 Scientists Develop Assay for Characterizing Editing-Related Features of Novel CRISPR/Cas9 Systems Oct 8, 2015 DuPont, Caribou Biosciences Ink Strategic Alliance on CRISPR, Cross-License IP Jun 23, 2015 DuPont Pioneer Licenses Genome-Editing Tech from Vilnius University Apr 22, 2015 DuPont Inks Deal to Acquire Microbiome Firm Taxon Apr 21, 2015 VWR to Distribute DuPont Dx's PCR-based Platform in the US for Food Safety Testing Dec 3, 2014 Health Canada Extends Approval of DuPont E. Coli Assay for Food Safety Sep 30, 2014 IP Watch: Thermo Fisher, Luminex, DuPont, Others Win US Patents Premium Aug 28, 2014 Syngenta Inks Agricultural microRNA Collaboration with Nexgen Premium Aug 27, 2014 Applied Markets Watch: DuPont Listeria Assay Premium Aug 25, 2014 DuPont Listeria Assay Gets AOAC Certification Aug 12, 2014 IP Watch: DuPont, Ibis Biosciences, Hitachi, Others Win US Patents Premium Jul 31, 2014 Applied Markets Watch: DuPont BAX System Listeria Assay Premium Oct 10, 2013 Applied Markets Watch: Life Tech GlobalFiler Express Kit; DuPont BAX System Premium Oct 3, 2013 Applied Markets Watch: Bio-Rad dPCR for GMO Detection; DuPont BAX System Added to FSIS Guidebook Premium Sep 19, 2013 IP Update: Recent Patents Awarded to CNRS, CSIRO, DuPont Premium May 9, 2013 IP Update: Recent Patents, Patent Applications Awarded to Merck, DuPont, MIT, and More Premium May 2, 2013 Applied Markets Watch: Instant Labs Listeria Test; DuPont Salmonella Assay Premium Apr 11, 2013 IP Update: Recent Patents, Patent Applications Awarded to Medtronic, CSIRO, DuPont, and More Premium Mar 28, 2013 Applied Markets Watch: Promega PowerPlex Fusion; DuPont Forms Nutrition & Health Business Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.